ARPA-H commits $62.7 million to develop FDA-authorized AI for heart failure treatment
Source Summary
ARPA-H, a U.S. government agency funding advanced health research, will invest $62.7 million to develop artificial intelligence systems designed to guide heart failure treatment. The AI bots are intended to receive FDA authorization for clinical use.
Why it matters
This federal investment signals commitment to advancing AI-driven clinical tools for a major cardiovascular disease affecting millions of patients.
